These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9131728)

  • 1. Early recurrence of withdrawal symptoms under phenytoin and chronic alcohol use.
    Knoll B; Haefeli WE; Ladewig D; Stohler R
    Pharmacopsychiatry; 1997 Mar; 30(2):72-3. PubMed ID: 9131728
    [No Abstract]   [Full Text] [Related]  

  • 2. Metyrapone-induced withdrawal symptoms: symptoms in methadone-maintained patients.
    Kennedy JA; Hartman N; Sbriglio R; Khuri E; Albeck H; Kreek MJ
    NIDA Res Monogr; 1990; 105():416. PubMed ID: 1876057
    [No Abstract]   [Full Text] [Related]  

  • 3. Self-regulated opioid detoxification by humans: effects of methadone pretreatment.
    McLeod DR; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1982 Apr; 41():232-8. PubMed ID: 6811914
    [No Abstract]   [Full Text] [Related]  

  • 4. A pilot study of a Neuro-Stimulator Device vs. methadone in alleviating opiate withdrawal symptoms.
    Elmoghazy E; Johnson BD; Alling FA
    NIDA Res Monogr; 1989; 95():388-9. PubMed ID: 2701306
    [No Abstract]   [Full Text] [Related]  

  • 5. Use predicts treatment outcome, not opiate dependence or withdrawal.
    Kosten TA; Bianchi MS; Kosten TR
    NIDA Res Monogr; 1989; 95():459-60. PubMed ID: 2641030
    [No Abstract]   [Full Text] [Related]  

  • 6. Low efficacy of non-opioid drugs in opioid withdrawal symptoms.
    Hermann D; Klages E; Welzel H; Mann K; Croissant B
    Addict Biol; 2005 Jun; 10(2):165-9. PubMed ID: 16191669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absence of opioid withdrawal symptoms in patients receiving methadone and the protease inhibitor lopinavir-ritonavir.
    Clarke S; Mulcahy F; Bergin C; Reynolds H; Boyle N; Barry M; Back DJ
    Clin Infect Dis; 2002 Apr; 34(8):1143-5. PubMed ID: 11915005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproic acid, unlike other anticonvulsants, has no effect on methadone metabolism: two cases.
    Saxon AJ; Whittaker S; Hawker CS
    J Clin Psychiatry; 1989 Jun; 50(6):228-9. PubMed ID: 2498296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contingency management of supplemental drug use during methadone maintenance treatment.
    Stitzer ML; Bigelow GE; Liebson IA; McCaul ME
    NIDA Res Monogr; 1984; 46():84-103. PubMed ID: 6145096
    [No Abstract]   [Full Text] [Related]  

  • 10. Outpatient comparison of buprenorphine and methadone maintenance. I. Effects on opiate use and self-reported adverse effects and withdrawal symptomatology.
    Johnson RE; Fudala PJ; Jaffe JH
    NIDA Res Monogr; 1990; 105():585-6. PubMed ID: 1876130
    [No Abstract]   [Full Text] [Related]  

  • 11. Self-administration of clonidine and oxazepam by methadone detoxification patients.
    Preston KL; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1984 Mar; 49():192-8. PubMed ID: 6434959
    [No Abstract]   [Full Text] [Related]  

  • 12. Methadone detoxification: effects of methadone dose versus time in treatment.
    McCaul ME; Stitzer ML; Bigelow GE; Liebson IA
    NIDA Res Monogr; 1984 Mar; 49():269-74. PubMed ID: 6434971
    [No Abstract]   [Full Text] [Related]  

  • 13. Slow-release oral morphine for maintenance treatment of opioid addicts intolerant to methadone or with inadequate withdrawal suppression.
    Kastelic A; Dubajic G; Strbad E
    Addiction; 2008 Nov; 103(11):1837-46. PubMed ID: 19032534
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Depressive disorders in management of drug dependent patients. Methadone maintenance].
    Laqueille X; Spadone C
    Encephale; 1995 Dec; 21 Spec No 4():11-4. PubMed ID: 8808339
    [No Abstract]   [Full Text] [Related]  

  • 15. Methadone withdrawal psychosis.
    Levinson I; Galynker II; Rosenthal RN
    J Clin Psychiatry; 1995 Feb; 56(2):73-6. PubMed ID: 7852256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [EMG abnormalities in REM sleep of addicted patients].
    Hemmeter U; Kocher R; Ladewig D; Holsboer-Trachsler E
    Ther Umsch; 1993 Mar; 50(3):169-77. PubMed ID: 8475470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two new rating scales for opiate withdrawal.
    Handelsman L; Cochrane KJ; Aronson MJ; Ness R; Rubinstein KJ; Kanof PD
    Am J Drug Alcohol Abuse; 1987; 13(3):293-308. PubMed ID: 3687892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Ultrashort withdrawal from opiate dependence].
    Scherbaum N; Kienbaum P
    Med Monatsschr Pharm; 2003 Aug; 26(8):278-82. PubMed ID: 12953381
    [No Abstract]   [Full Text] [Related]  

  • 19. Methodology for assessing agents that suppress methadone withdrawal: a study of baclofen.
    Jaffe JH; Kanzler M; Brady R; Friedman L
    NIDA Res Monogr; 1982 Apr; 41():269-75. PubMed ID: 6811918
    [No Abstract]   [Full Text] [Related]  

  • 20. Patterns of symptom complaints in methadone maintenance patients.
    Dyer KR; White JM
    Addiction; 1997 Nov; 92(11):1445-55. PubMed ID: 9519488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.